The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Structure and Interactions of the Human Programmed Cell Death 1 Receptor
Open accessAbstract
PD-1, a receptor expressed by T cells, B cells, and monocytes, is a potent regulator of immune responses and a promising therapeutic target. The structure and interactions of human PD-1 are, however, incompletely characterized. We present the solution nuclear magnetic resonance (NMR)-based structure of the human PD-1 extracellular region and detailed analyses of its interactions with its ligands, PD-L1 and PD-L2. PD-1 has typical immunoglobulin superfamily topology but differs at the edge of the GFCC' sheet, which is flexible and completely lacks a C" strand. Changes in PD-1 backbone NMR signals induced by ligand binding suggest that, whereas binding is centered on the GFCC' sheet, PD-1 is engaged by its two ligands differently and in ways incompletely explained by crystal structures of mouse PD-1 · ligand complexes. The affinities of these interactions and that of PD-L1 with the costimulatory protein B7-1, measured using surface plasmon resonance, are significantly weaker than expected. The 3-4-fold greater affinity of PD-L2 versus PD-L1 for human PD-1 is principally due to the 3-fold smaller dissociation rate for PD-L2 binding. Isothermal titration calorimetry revealed that the PD-1/PD-L1 interaction is entropically driven, whereas PD-1/PD-L2 binding has a large enthalpic component. Mathematical simulations based on the biophysical data and quantitative expression data suggest an unexpectedly limited contribution of PD-L2 to PD-1 ligation during interactions of activated T cells with antigen-presenting cells. These findings provide a rigorous structural and biophysical framework for interpreting the important functions of PD-1 and reveal that potent inhibitory signaling can be initiated by weakly interacting receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
The Amber biomolecular simulation programs
Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20290 · Cited by 9,535
MOLMOL: A program for display and analysis of macromolecular structures
Koradi, R., Billeter, M., & Wüthrich, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00009-4 · Cited by 7,163
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Bell, G. I. (1978) · Science · doi:10.1126/science.347575 · Cited by 4,328
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,896
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Self-citationRapid measurement of binding constants and heats of binding using a new titration calorimeter
Wiseman, T., Williston, S., Brandts, J. F., & Lin, L.-N. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90213-3 · Cited by 2,675
TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts
Shen, Y., Delaglio, F., Cornilescu, G., & Bax, A. (2009) · Journal of Biomolecular NMR · doi:10.1007/s10858-009-9333-z · Cited by 2,516
Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,079
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860 · cited 1×
“Consistent with its formidable binding properties, it is suggested that CTLA-4 exerts its inhibitory effect on CD28 signaling by depleting their mutual ligands B7-1 andB7-2 from apposing cells via trans-endocytosis (63).”
BackgroundButte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,732
Herrmann, T., Güntert, P., & Wüthrich, K. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00241-3 · Cited by 1,460
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.12.009 · Cited by 1,329
Yokosuka, T., Takamatsu, M., Kobayashi-Imanishi, W., Hashimoto-Tane, A., Azuma, M., & Saito, T. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112741 · Cited by 1,161
DaliLite workbench for protein structure comparison
Holm, L., & Park, J. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.6.566 · Cited by 888
B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells
Tseng, S.-Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J. E., Pai, S. I., Shalabi, A., Shin, T., Pardoll, D. M., & Tsuchiya, H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.839 · Cited by 872
PD-1 signaling in primary T cells
Riley, J. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00767.x · Cited by 778
The Interaction Properties of Costimulatory Molecules Revisited
Collins, A. V., Brodie, D. W., Gilbert, R. J. C., Iaboni, A., Manso-Sancho, R., Walse, B., Stuart, D. I., van der Merwe, P. A., & Davis, S. J. (2002) · Immunity · doi:10.1016/s1074-7613(02)00362-x · Cited by 684
Self-citationReversal of the TCR Stop Signal by CTLA-4
Schneider, H., Downey, J., Smith, A., Zinselmeyer, B. H., Rush, C., Brewer, J. M., Wei, B., Hogg, N., Garside, P., & Rudd, C. E. (2006) · Science · doi:10.1126/science.1131078 · Cited by 621
Urbani, S., Amadei, B., Tola, D., Massari, M., Schivazappa, S., Missale, G., & Ferrari, C. (2006) · Journal of Virology · doi:10.1128/jvi.01177-06 · Cited by 588
CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics
van der Merwe, P. A., Bodian, D. L., Daenke, S., Linsley, P., & Davis, S. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.393 · Cited by 551 · cited 3×
“Equilibrium binding analysis was undertaken as described (28, 29).”
MethodSelf-citationCrystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses
Stamper, C. C., Zhang, Y., Tobin, J. F., Erbe, D. V., Ikemizu, S., Davis, S. J., Stahl, M. L., Seehra, J., Somers, W. S., & Mosyak, L. (2001) · Nature · doi:10.1038/35069118 · Cited by 489
Self-citationRadziewicz, H., Ibegbu, C. C., Fernandez, M. L., Workowski, K. A., Obideen, K., Wehbi, M., Hanson, H. L., Steinberg, J. P., Masopust, D., Wherry, E. J., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02021-06 · Cited by 483
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
Lin, D. Y.-W., Tanaka, Y., Iwasaki, M., Gittis, A. G., Su, H.-P., Mikami, B., Okazaki, T., Honjo, T., Minato, N., & Garboczi, D. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712278105 · Cited by 457
Molecular Dynamics Simulations of Nucleic Acids with a Generalized Born Solvation Model
Tsui, V., & Case, D. A. (2000) · Journal of the American Chemical Society · doi:10.1021/ja9939385 · Cited by 432
Structural and Functional Analysis of the Costimulatory Receptor Programmed Death-1
Zhang, X., Schwartz, J.-C. D., Guo, X., Bhatia, S., Cao, E., Chen, L., Zhang, Z.-Y., Edidin, M. A., Nathenson, S. G., & Almo, S. C. (2004) · Immunity · doi:10.1016/s1074-7613(04)00051-2 · Cited by 410
B7-H1 Determines Accumulation and Deletion of Intrahepatic CD8+ T Lymphocytes
Dong, H., Zhu, G., Tamada, K., Flies, D. B., van Deursen, J. M. A., & Chen, L. (2004) · Immunity · doi:10.1016/s1074-7613(04)00050-0 · Cited by 372
Ladbury, J. E., & Chowdhry, B. Z. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90063-0 · Cited by 360
Self-citationGüntert, P., & Wüthrich, K. (1991) · Journal of Biomolecular NMR · doi:10.1007/bf02192866 · Cited by 328
Functional expression of B7/BB1 on activated T lymphocytes.
Azuma, M., Yssel, H., Phillips, J. H., Spits, H., & Lanier, L. L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.3.845 · Cited by 267
Localizing the NADP+ binding site on the MurB enzyme by NMR
Farmer, B. T., Constantine, K. L., Goldfarb, V., Friedrichs, M. S., Wittekind, M., Yanchunas, J., Robertson, J. G., & Mueller, L. (1996) · Nature Structural Biology · doi:10.1038/nsb1296-995 · Cited by 228
Interaction of human PD-L1 and B7-1
Butte, M. J., Peña-Cruz, V., Kim, M.-J., Freeman, G. J., & Sharpe, A. H. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.014 · Cited by 228
Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2
Lázár-Molnár, E., Yan, Q., Cao, E., Ramagopal, U., Nathenson, S. G., & Almo, S. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804453105 · Cited by 206
Kasprowicz, V., Schulze zur Wiesch, J., Kuntzen, T., Nolan, B. E., Longworth, S., Berical, A., Blum, J., McMahon, C., Reyor, L. L., Elias, N., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02474-07 · Cited by 202
Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis
Dong, H., Strome, S. E., Matteson, E. L., Moder, K. G., Flies, D. B., Zhu, G., Tamura, H., Driscoll, C. L. W., & Chen, L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16015 · Cited by 190
Crystal structure of a soluble CD28-Fab complex
Evans, E. J., Esnouf, R. M., Manso-Sancho, R., Gilbert, R. J. C., James, J. R., Yu, C., Fennelly, J. A., Vowles, C., Hanke, T., Walse, B., et al. (2005) · Nature Immunology · doi:10.1038/ni1170 · Cited by 180
Self-citationVeverka, V., Crabbe, T., Bird, I. N., Lennie, G., Muskett, F. W., Taylor, R. J., & Carr, M. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210693 · Cited by 176
Self-citationPetrovas, C., Price, D. A., Mattapallil, J., Ambrozak, D. R., Geldmacher, C., Cecchinato, V., Vaccari, M., Tryniszewska, E., Gostick, E., Roederer, M., et al. (2007) · Blood · doi:10.1182/blood-2007-01-069112 · Cited by 173
Self-citationIn vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses
Shin, T., Yoshimura, K., Shin, T., Crafton, E. B., Tsuchiya, H., Housseau, F., Koseki, H., Schulick, R. D., Chen, L., & Pardoll, D. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050072 · Cited by 159
A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese
Kong, E. K., Prokunina‐Olsson, L., Wong, W. H. S., Lau, C., Chan, T. M., Alarcón-Riquelme, M. E., & Lau, Y. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20966 · Cited by 148
Ferreirós-Vidal, I., Gómez-Reino, J. J., Barros, F., Carracedo, Á., Carreira, P. E., Gonzáléz‐Escribano, F., Liz, M., Martin, J. J., Ordi‐Ros, J., Vicario, J. L., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20436 · Cited by 120
PD‐L2:PD‐1 involvement in T cell proliferation, cytokine production, and integrin‐mediated adhesion
Saunders, P. A., Hendrycks, V. R., Lidinsky, W. A., & Woods, M. L. (2005) · European Journal of Immunology · doi:10.1002/eji.200526347 · Cited by 120
Williamson, R. A., Carr, M. D., Frenkiel, T. A., Feeney, J., & Freedman, R. B. (1997) · Biochemistry · doi:10.1021/bi9712091 · Cited by 116
Self-citationDavis, S. J., Ward, H. A., Puklavec, M. J., Willis, A. C., Williams, A., & Barclay, A. N. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86961-7 · Cited by 115
Self-citationB7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro
Sansom, D. M., & Hall, N. D. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230148 · Cited by 110
Muskett, F. W., Frenkiel, T. A., Feeney, J., Freedman, R. B., Carr, M. D., & Williamson, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21736 · Cited by 88
Self-citationDas, M. R. P., Zamvil, S. S., Borriello, F., Weiner, H. L., Sharpe, A. H., & Kuchroo, V. K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250134 · Cited by 73
Rigid-body Ligand Recognition Drives Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Receptor Triggering
Yu, C., Sonnen, A. F. ‐., George, R., Dessailly, B. H., Stagg, L., Evans, E. J., Orengo, C. A., Stuart, D. I., Ladbury, J. E., Ikemizu, S., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182394 · Cited by 55
Self-citationA Theoretical Framework for Quantitative Analysis of the Molecular Basis of Costimulation
Jansson, A., Barnes, E. J., Klenerman, P., Harlén, M., Sørensen, P., Davis, S. J., & Nilsson, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1575 · Cited by 52
Self-citationPDCD1: a tissue-specific susceptibility locus for inherited inflammatory disorders
James, E. S., Harney, S. M. J., Wordsworth, B. P., Cookson, W., Davis, S. J., & Moffatt, M. F. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364223 · Cited by 48
Self-citationHigh Resolution NMR-based Model for the Structure of a scFv-IL-1β Complex
Wilkinson, I. C., Hall, C. J., Veverka, V., Shi, J., Muskett, F. W., Stephens, P. E., Taylor, R. J., Henry, A. J., & Carr, M. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025304 · Cited by 42
Self-citationCrystal Structure and Binding Properties of the CD2 and CD244 (2B4)-binding Protein, CD48
Evans, E. J., Castro, M. A., O’Brien, R., Kearney, A., Walsh, H., Sparks, L. M., Tucknott, M. G., Davies, E., Carmo, A. M., van der Merwe, P. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601314200 · Cited by 42
Self-citationRenshaw, P. S., Veverka, V., Kelly, G. P., Frenkiel, T. A., Williamson, R. A., Gordon, S. V., Hewinson, R. G., & Carr, M. D. (2004) · Journal of Biomolecular NMR · doi:10.1023/b:jnmr.0000048852.40853.5c · Cited by 40
Self-citationNMR Assignment of the mTOR Domain Responsible for Rapamycin Binding
Veverka, V., Lennie, G., Crabbe, T., Bird, I., Taylor, R. J., & Carr, M. D. (2006) · Journal of Biomolecular NMR · doi:10.1007/s10858-005-4324-1 · Cited by 36
Self-citationWaters, L. C., Böhm, M., Veverka, V., Muskett, F. W., Frenkiel, T. A., Kelly, G. P., Prescott, A., Dosanjh, N. S., Klempnauer, K., & Carr, M. D. (2006) · Journal of Biomolecular NMR · doi:10.1007/s10858-005-5887-6 · Cited by 9
Self-citationQuantitative analysis predicts the relative therapeutic efficacy of different forms of CTLA4Ig
Jansson, A., & Davis, S. J. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.09.021 · Cited by 3
Self-citation
Cited by
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Ohaegbulam, K. C., Assal, A., Lazar-Molnar, E., Yao, Y., & Zang, X. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.10.009 · Cited by 843
Wang, C., Thudium, K. B., Han, M., Wang, X.-T., Huang, H., Feingersh, D., Garcia, C., Wu, Y., Kuhne, M., Srinivasan, M., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0040 · Cited by 601
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Korman, A. J., Garrett-Thomson, S. C., & Lonberg, N. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00345-8 · Cited by 548
Patsoukis, N., Wang, Q., Strauss, L., & Boussiotis, V. A. (2020) · Science Advances · doi:10.1126/sciadv.abd2712 · Cited by 535
Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
Zak, K. M., Kitel, R., Przetocka, S., Golik, P., Guzik, K., Musielak, B., Dömling, A., Dubin, G., & Holak, T. A. (2015) · Structure · doi:10.1016/j.str.2015.09.010 · Cited by 531
Metadata
- Authors
- Cheng, X., Veverka, V., Radhakrishnan, A., Waters, L. C., Muskett, F. W., Morgan, S. H., Huo, J., Yu, C., Evans, E. J., Leslie, A. J., Griffiths, M., Stubberfield, C., Griffin, R., Henry, A. J., Jansson, A., Ladbury, J. E., Ikemizu, S., Carr, M. D., & Davis, S. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 288
- Issue
- 17
- Pages
- 11771-11785
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2090031443
- Cited by
- 323
- References
- 66
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.